Skip to main content
Ribicon Pharma
About
Products
Solid-Tumor Biomarkers
  • Alpha-fetoprotein (AFP)
  • CA-125
  • Gastric Carcinoma GC-REAAD
  • Hepatocellular Carcinoma HCC-REAAD
  • Nasopharyngeal Carcinoma NPC-REAAD
Targeted Therapeutics
  • Tepadina (thiotepa)
  • Phelinun (melphalan)
Ophthalmology
  • Bimatoprost eye drops
  • Latanoprost eye drops
Cardiology
  • Vectraplex ECG
  • Troponin test
Veterinary Diagnostics
    Infant Formulas & Children’s Food
      ServicesContact
      FR/EN
      Partner with us

      Our commitment

      Accessibility

      Ribicon Pharma is developing this website with the goal of conforming to WCAG 2.2 Level AA and providing an inclusive experience across devices and assistive technologies.

      Design and development

      The website uses semantic structure, keyboard-accessible navigation, visible focus states, adaptable layouts, meaningful image descriptions, and reduced-motion support.

      Feedback

      If you encounter an accessibility barrier, email info@ribicongroup.com and describe the page and assistance you need.

      Ribicon Pharma

      Specialized healthcare, thoughtfully brought to market.

      Explore

      AboutPortfolioServices

      Contact

      Montréal, Québec, Canada

      info@ribicongroup.com

      Information

      PrivacyAccessibility

      © 2026 Ribicon Pharma. All rights reserved.

      Information on this website is not medical advice.